Dechra takes on distribution of Ketodolor®
Friday 24 February 2023
Dechra has taken on the distribution of Ketodolor®, the non-steroidal anti-inflammatory (NSAID) and anti-rheumatic product for cattle, pigs and horses.
Dechra has taken on the distribution of Ketodolor®, the non-steroidal anti-inflammatory (NSAID) and anti-rheumatic product for cattle, pigs and horses.
Ketodolor joins Meloxidolor® (meloxicam) in Dechra’s NSAID range and is a clear yellow solution for injection. It contains 100 mg/ml ketoprofen as its active ingredient and is indicated to reduce pain associated with lameness and parturient paresis in cattle, as well as improve the recovery rates in acute endotoxic mastitis in cattle. It also reduces pyrexia and distress associated with bacterial respiratory disease.
It has a zero-milk withdrawal period in cattle, making it easy for farmers to use without discarding milk, and features a flexible withdrawal time in meat, with the shortest being for IV; for cattle meat the withdrawal time for IV administration is one day and for IM administration is four days. If required, it can be used for three consecutive days in cattle.
In pigs, it is licensed to reduce pyrexia and respiratory rate associated with bacterial or viral respiratory disease and supports treatment of mastitis, metritis and agalactia syndrome in sows. The meat withdrawal period is four days.
In horses, it is indicated to alleviate inflammation and pain associated with musculoskeletal disorders and visceral pain associated with colic.
Alana McGlade, national sales manager at Dechra, comments:
“We are delighted to have taken on the distribution of Ketodolor which will provide vets with flexible options when managing pain across a variety of species, including the management of pain associated with lameness in cattle.”
For further information on Dechra’s NSAID range that includes Ketodolor and Meloxidolor, please contact your local Dechra territory manager or visit www.dechra.co.uk/products/livestock/prescription
For press information, please contact:
Jessica Henman, Vita Communications
Email: jessica.henman@vitacomms.com
Tel: 01488 683862 or 07771 897954
NOTES TO EDITORS
Ketodolor® contains ketoprofen. Legal category: UK POM-V IE-POM.
Meloxidolor® contains meloxicam. Legal category: UK POM-V IE-POM.
Please refer to the product packaging and leaflets for information about side effects, precautions, warnings and contra-indications.
Use medicines responsibly (www.noah.co.uk/responsible).
Dechra Veterinary Products Ltd is part of Dechra Pharmaceuticals PLC (‘Dechra’) and offers a range of pharmaceutical products and instruments to veterinary practices in the UK and Republic of Ireland. Dechra Veterinary Products specialises in the development and marketing of licensed branded pharmaceuticals in the global veterinary market.
An innovative company, it invests in the development of products and services while providing a high level of support to vets. Dechra's expertise spans dermatology, endocrinology, equine medicine, ophthalmology, critical care and diet and nutrition. Major brands include: Vetoryl® Capsules, for the treatment of canine hyperadrenocorticism (Cushing's syndrome); Dermatology brands Canaural®, Isaderm® Gel and Malaseb® Shampoo; Felimazole® Tablets, for treating feline hyperthyroidism; Equipalazone®, the anti-inflammatory and analgesic for equine musculoskeletal disorders and ophthalmic product Isathal®.